New Materials for an Implantable Blood Pump. Rotary blood pumps are at the leading edge of heart assist technology. VentrAssist has developed an innovative rotary blood pump with a hydro-dynamically suspended impeller. Advanced surface modifications will enable the device to be fabricated from polymers; this will make the device light, more compatible with the human body and less costly to produce. Surface treatments and coatings will be applied using ion implantation, to impart the required ....New Materials for an Implantable Blood Pump. Rotary blood pumps are at the leading edge of heart assist technology. VentrAssist has developed an innovative rotary blood pump with a hydro-dynamically suspended impeller. Advanced surface modifications will enable the device to be fabricated from polymers; this will make the device light, more compatible with the human body and less costly to produce. Surface treatments and coatings will be applied using ion implantation, to impart the required dimensional stability, impermeability and wear resistance. Following sophisticated experiments of modified materials, the best candidates will be used in prototype devices, for final selection of the optimal materials for the new device.Read moreRead less
The Scale-up and Evaluation of a Novel Dense Gas Technology Platform for the Production of Particles for Aerosol Drug Delivery. This project provides a unique opportunity to develop an Australian-invented technology in particle engineering, enabling it to enter the international pharmaceutical market. This will enhance the growth of Australia's pharmaceutical research and development, and benefit the Australian pharmaceutical industry. The outcome will also contribute to improvements in the heal ....The Scale-up and Evaluation of a Novel Dense Gas Technology Platform for the Production of Particles for Aerosol Drug Delivery. This project provides a unique opportunity to develop an Australian-invented technology in particle engineering, enabling it to enter the international pharmaceutical market. This will enhance the growth of Australia's pharmaceutical research and development, and benefit the Australian pharmaceutical industry. The outcome will also contribute to improvements in the health and well-being of Australians. The research falls within the Designated National Research Priority of Frontier Technologies for Building and Transforming Australian Industries.Read moreRead less
Modulation of protein folding pathways: a new platform technology for molecular medicine. Misfolding of proteins is becoming recognised as a major cause of inherited disease. We propose to develop a chemical agent that will optimise the folding of alpha1-antitrypsin (AAT), misfolding of which gives rise to inheritable liver and lung disease. This agent will have potential application as a therapy for sufferers of AAT-misfolding disease and for improving the yield of AAT purified from human plasm ....Modulation of protein folding pathways: a new platform technology for molecular medicine. Misfolding of proteins is becoming recognised as a major cause of inherited disease. We propose to develop a chemical agent that will optimise the folding of alpha1-antitrypsin (AAT), misfolding of which gives rise to inheritable liver and lung disease. This agent will have potential application as a therapy for sufferers of AAT-misfolding disease and for improving the yield of AAT purified from human plasma, which is the current agent used to treat patients with AAT-misfolding disease.Read moreRead less
Understanding glycopolymer interactions with the extracellular matrix. This project aims to advance knowledge of the biochemical and biophysical structure of the endothelial glycocalyx, a dynamic cell surface extracellular matrix rich in proteoglycans and glycosaminoglycans. It will be the first to explore how charged glycopolymers interact with this dynamic interface with the goal to develop a model of the glycocalyx lifecycle. This project is expected to enable the transfer of skills, knowledg ....Understanding glycopolymer interactions with the extracellular matrix. This project aims to advance knowledge of the biochemical and biophysical structure of the endothelial glycocalyx, a dynamic cell surface extracellular matrix rich in proteoglycans and glycosaminoglycans. It will be the first to explore how charged glycopolymers interact with this dynamic interface with the goal to develop a model of the glycocalyx lifecycle. This project is expected to enable the transfer of skills, knowledge and ideas as well as advanced research and industrial training for young scientists. Knowledge derived from this project is expected to enable future innovation in molecules with tailored interactions with the glycocalyx with significant benefits for researchers, manufacturers and end users. Read moreRead less
Hermetic bonding of biomedical polymers for cardiac-assist devices. The use of a polymeric ventricular assist device will bring a much better quality of life to patients with end-stage heart failure. The project will address the remaining challenge, the creation of a hermetic polymer seal, enabling the development of a small, light and highly efficient heart pump. The project has the potential to improve the lives of many Australians as our demographic profile shifts towards older people. Patie ....Hermetic bonding of biomedical polymers for cardiac-assist devices. The use of a polymeric ventricular assist device will bring a much better quality of life to patients with end-stage heart failure. The project will address the remaining challenge, the creation of a hermetic polymer seal, enabling the development of a small, light and highly efficient heart pump. The project has the potential to improve the lives of many Australians as our demographic profile shifts towards older people. Patients with advanced heart failure will live longer, with a higher quality of life. It will assist heart failure sufferers to remain productive members of our community, because many people who use the device will be fit to return to work.Read moreRead less
Novel antimicrobial surface coatings for Cochlear implants. The objective of this project is to develop new antimicrobial coatings for materials used to manufacture biomedical devices. Infection associated with the use of biomaterials such as biomedical implants, catheters and orthopaedic prostheses is a major barrier to the use of these devices. The coatings that the project plans to develop are based on novel antimicrobials which have been shown to prevent adhesion and colonisation of biomater ....Novel antimicrobial surface coatings for Cochlear implants. The objective of this project is to develop new antimicrobial coatings for materials used to manufacture biomedical devices. Infection associated with the use of biomaterials such as biomedical implants, catheters and orthopaedic prostheses is a major barrier to the use of these devices. The coatings that the project plans to develop are based on novel antimicrobials which have been shown to prevent adhesion and colonisation of biomaterials by bacteria in vivo. This strategy has the potential to prevent device-related infections and revolutionise the biomaterials industry.Read moreRead less
Rapid Development of Biocompatible Stent Grafts for Aortic Aneurysms. Weakening of the aorta may cause an aneurysm. The present technique of its treatment involves replacing the weakened portion of the aorta with a synthetic graft. Failure of this treatment often occurs due to non-compatibility of the stent graft with natural aorta. One possible reason for this is a mismatch between elastic natural aorta and the non-elastic artificial graft. The core component of our project is the selection and ....Rapid Development of Biocompatible Stent Grafts for Aortic Aneurysms. Weakening of the aorta may cause an aneurysm. The present technique of its treatment involves replacing the weakened portion of the aorta with a synthetic graft. Failure of this treatment often occurs due to non-compatibility of the stent graft with natural aorta. One possible reason for this is a mismatch between elastic natural aorta and the non-elastic artificial graft. The core component of our project is the selection and development of a suitable biomaterial and optimization of the stent design based on hemodynamics flow analysis and its fabrication with the Fused Deposition Modelling (FDM) process.Read moreRead less
Advanced Materials for Stents. The polymer based materials targeted for production in this project will bring unique capabilities to the field of stent design. A multi-component degradable stent system is expected to bring significant improvements in vascular therapeutic treatments for a wide range of illnesses and applications. This will have significant advantages over current treatment and will have a positive impact on the quality of life of patients. The project brings together world leader ....Advanced Materials for Stents. The polymer based materials targeted for production in this project will bring unique capabilities to the field of stent design. A multi-component degradable stent system is expected to bring significant improvements in vascular therapeutic treatments for a wide range of illnesses and applications. This will have significant advantages over current treatment and will have a positive impact on the quality of life of patients. The project brings together world leaders in their respective fields to address a highly multidisciplinary are of research and will provide excellent training for the PhDs and post doctoral research associates, enabling them to work in and contribute to the development of new biomedical industries in Australia.Read moreRead less
In Vitro Study of Hemodynamic Stresses and Endothelialization of Artificial Coronary Arteries. Restenosis (recurrence of the disease) is a major problem in the case of patients undergoing artificial artery by-pass surgery. Ideally the design for manufacturing the scaffold for cell adhesion of the artery should factor in hemodynamic forces and optimised geometry to withstand the hemodynamic stresses and other forces. This project aims to investigate the material for manufacturing the artificial a ....In Vitro Study of Hemodynamic Stresses and Endothelialization of Artificial Coronary Arteries. Restenosis (recurrence of the disease) is a major problem in the case of patients undergoing artificial artery by-pass surgery. Ideally the design for manufacturing the scaffold for cell adhesion of the artery should factor in hemodynamic forces and optimised geometry to withstand the hemodynamic stresses and other forces. This project aims to investigate the material for manufacturing the artificial artery using Fused Deposition Modeling and to develop methods for the establishment of endothelium on the artificial artery, concluding a restenosis-free solution for by-pass surgery. The knowledge gained through this work would be applicable to the design of other prosthetic devices.Read moreRead less
Development and characterisation of novel hydrogel systems for drug delivery. The aims of this project are to develop and characterise hydrogel formulations for delivery of active agents, such as protein drugs, and to examine the biological responses to drug loaded hydrogels. In many medical and industrial fields, it is advantageous to control the release of active agents. Controlled release can decrease the dose of active that must be administered, sustain a more constant level of the agent ....Development and characterisation of novel hydrogel systems for drug delivery. The aims of this project are to develop and characterise hydrogel formulations for delivery of active agents, such as protein drugs, and to examine the biological responses to drug loaded hydrogels. In many medical and industrial fields, it is advantageous to control the release of active agents. Controlled release can decrease the dose of active that must be administered, sustain a more constant level of the agent in the environment and can localise the agent at the site where it is needed. This project will advance the theoretical knowledge of polymer degradation combined with protein release, will develop controlled release hydrogel technology that can be applied to medical devices and will train a postgraduate student in biomaterials and drug delivery.Read moreRead less